1‐year mortality · previously untreated patients with mRCC
Interferon‐α combined with targeted therapies showed no clear difference in 1‐year mortality compared with standard targeted therapy (moderate certainty).
1 finding from 1 review
Quality of life · previously untreated patients with mRCC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stone recurrence (assessed as symptomatic renal colic/stone expulsion episodes and imaging) · participants with a prior history of nephrolithiasis
Increased water intake may leads to lower stone recurrence (assessed as symptomatic renal colic/stone… compared with standard water intake (low certainty).
1 finding from 1 review
Time to recurrence · participants with a prior history of nephrolithiasis
Increased water intake may leads to lower time to recurrence (absolute event rate based on 5‐year compared with standard water intake (low certainty).
1 finding from 1 review
Adverse events · participants with a prior history of nephrolithiasis
1 finding from 1 review
Time to death from any cause (here: overall mortality at 12‐month · advanced hormone‐sensitive prostate cancer
Early probably leads to lower time to death of any cause (here: all‐cause mortality at 5 years) compared with deferred AST (moderate certainty).
1 finding from 1 review
Serious adverse events · advanced hormone‐sensitive prostate cancer
Early showed no clear difference in serious adverse events compared with deferred AST (low certainty).
1 finding from 1 review
Time to death from prostate cancerMedian · advanced hormone‐sensitive prostate cancer
Early probably leads to lower time to death from prostate cancer (here: prostate cancer mortality… compared with deferred AST (moderate certainty).
1 finding from 1 review
Skeletal events · advanced hormone‐sensitive prostate cancer
Early may leads to lower skeletal events compared with deferred AST (low certainty).
1 finding from 1 review
Fatigue · advanced hormone‐sensitive prostate cancer
Early may leads to higher fatigue compared with deferred AST (low certainty).
1 finding from 1 review
Heart failure · advanced hormone‐sensitive prostate cancer
Early may leads to higher heart failure compared with deferred AST (low certainty).
1 finding from 1 review
Global quality of life · advanced hormone‐sensitive prostate cancer
1 finding from 1 review
Systemic UTI · people undergoing cystoscopy
Antimicrobial showed no clear difference in systemic UTI compared with placebo or no antibiotics (low certainty).
1 finding from 1 review
Number of participants with symptomatic UTI · people undergoing cystoscopy
Antimicrobial may leads to lower symptomatic UTI compared with placebo or no antibiotics (low certainty).
1 finding from 1 review
Serious adverse events · people undergoing cystoscopy
It is very uncertain whether antimicrobial changes serious adverse events compared with placebo or no antibiotics (very low certainty).
1 finding from 1 review
Minor adverse events · people undergoing cystoscopy
Antimicrobial showed no clear difference in minor adverse events compared with placebo or no antibiotics (low certainty).
1 finding from 1 review
Localized UTI · people undergoing cystoscopy
It is very uncertain whether antimicrobial changes localized UTI compared with placebo or no antibiotics (very low certainty).
1 finding from 1 review
Bacterial resistance · people undergoing cystoscopy
It is very uncertain whether antimicrobial changes bacterial resistance compared with placebo or no antibiotics (very low certainty).
1 finding from 1 review
Proportion of participants who developed a new urinary stone · children with idiopathic urinary calculi treated with shockwave lithotripsy
Potassium citrate may leads to lower proportion of participants who developed a new urinary stone compared with no intervention (low certainty).
1 finding from 1 review
Proportion of participants with adverse events while undergoing intervention · children with idiopathic urinary calculi treated with shockwave lithotripsy
It is very uncertain whether potassium citrate changes proportion of participants with adverse events while undergoing… compared with no intervention (very low certainty).
1 finding from 1 review